NEXENTIS TECHNOLOGIES INC. Operating Lease, Payments
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Operating Lease, Payments of $24.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-03-31
- NEXENTIS TECHNOLOGIES INC. operating lease, payments for fiscal 2025 was $24.00K, a 60.66% decline from fiscal 2024.
- NEXENTIS TECHNOLOGIES INC. operating lease, payments for fiscal 2024 was $61.00K, a 19.61% increase from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. operating lease, payments for fiscal 2023 was $51.00K, a 18.63% decline from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. operating lease, payments for fiscal 2022 was $62.68K, a 60.83% increase from fiscal 2021.
| Period end | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|
| 2025-12-31 | $24.00K 10-K · filed 2026-03-31 | |
| 2024-12-31 | $61.00K 10-K · filed 2026-03-31 | |
| 2023-12-31 | $51.00K 10-K · filed 2025-03-31 | $51.35K 10-K · filed 2024-04-01 |
| 2022-12-31 | $62.68K 10-K · filed 2024-04-01 | |
| 2021-12-31 | $38.97K 10-K · filed 2023-03-27 | |
| 2020-12-31 | $40.97K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |